Solventum Corp
SOLVAPI behind this page
SOLV Q1 2026 request
Playground key active
/api/financials?ticker=SOLV&year=2026&quarter=1
Pick an endpoint and run the request.Income Statement
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Revenue | 2,007 | 2,070 | -3.0% |
Show Product Lines breakouts |
|||
| Cost of software and rentals | 493 | 473 | +4.2% |
| Product | 1,513 | 1,597 | -5.3% |
| Product · After Spin-Off | 17 | 20 | -15.0% |
Show Business Segments breakouts |
|||
| Dental Solutions · Operating Segments | 354 | 328 | +7.9% |
| Health Information Systems · Operating Segments | 342 | 329 | +4.0% |
| MedSurg · Advanced Wound Care | 497 | 448 | +10.9% |
| MedSurg · Infection Prevention and Surgical Solutions | 737 | 710 | +3.8% |
| MedSurg · Operating Segments | 1,234 | 1,157 | +6.7% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 76 | 76 | 0.0% |
| Operating Segments | 1,931 | 1,814 | +6.4% |
Show Related Party Transactions By Related Party breakouts |
|||
| Related Party | 17 | 20 | -15.0% |
| Cost of Revenue (Q) | — | — | — |
Show Product Lines breakouts |
|||
| Cost of software and rentals | 115 | 121 | -5.0% |
| Product | 796 | 835 | -4.7% |
| Product · After Spin-Off | 132 | 155 | -14.8% |
Show Related Party Transaction breakouts |
|||
| Master Supply Agreements · Related Party | 64 | 63 | +1.6% |
Show Related Party Transactions By Related Party breakouts |
|||
| Related Party | 11 | 15 | -26.7% |
| Gross Profit | 1,097 | 1,114 | -1.5% |
| Selling, General & Administrative | 827 | 769 | +7.5% |
Show Related Party Transaction breakouts |
|||
| After Spin-Off · Related Party | 56 | 67 | -16.4% |
| Research & Development | 189 | 193 | -2.1% |
Show Related Party Transaction breakouts |
|||
| After Spin-Off · Related Party | 2 | 3 | -33.3% |
| Operating Income | 81 | 152 | -46.7% |
Show Business Segments breakouts |
|||
| Dental Solutions · Operating Segments | 87 | 78 | +11.5% |
| Health Information Systems · Operating Segments | 130 | 109 | +19.3% |
| MedSurg · Operating Segments | 161 | 206 | -21.8% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 12 | 11 | +9.1% |
| Operating Segments | 379 | 393 | -3.6% |
| Interest Income Expense Nonoperating Net | 62 | 104 | -40.4% |
| Other Non-Operating Income (Expense) | 4 | 11 | -63.6% |
| Income Before Taxes | 16 | 38 | -57.9% |
| Income Tax Expense (Benefit) | 3 | -99 | +103.0% |
| Net Income | 13 | 137 | -90.5% |
Show Equity Components breakouts |
|||
| Retained Earnings | 13 | 137 | -90.5% |
| EPS (Basic) | 0.07 | 0.79 | -91.1% |
| EPS (Diluted) | 0.07 | 0.78 | -91.0% |
| Wtd Avg Shares (Basic) | 174.2 | 173.7 | +0.3% |
| Wtd Avg Shares (Diluted) | 175.5 | 174.8 | +0.4% |
| Cost of Revenue (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Dental Solutions · Operating Segments | 120 | 118 | +1.7% |
| Health Information Systems · Operating Segments | 80 | 88 | -9.1% |
| MedSurg · Operating Segments | 622 | 548 | +13.5% |
| Total Costs & Expenses (Q) | — | — | — |
Show Related Party Transaction breakouts |
|||
| Transition Agreement Services · Related Party | 105 | 137 | -23.4% |
| Operating Expenses (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Dental Solutions · Operating Segments | 148 | 132 | +12.1% |
| Health Information Systems · Operating Segments | 132 | 132 | 0.0% |
| MedSurg · Operating Segments | 451 | 404 | +11.6% |
| Comprehensive Income | -32 | 294 | -110.9% |
| Other Comprehensive Income | -45 | 157 | -128.7% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | 12 | 14 | -14.3% |
| Accumulated Gain Loss Net Cash Flow Hedge Parent | 7 | -11 | +163.6% |
| Accumulated Other Comprehensive Income | -45 | 157 | -128.7% |
| Accumulated Translation Adjustment | -63 | 154 | -140.9% |
| Operating Lease Lease Income | 151 | 144 | +4.9% |
Balance Sheet
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 561 | 534 | +5.1% |
| Accounts Receivable | 1,059 | 926 | +14.4% |
| Other Receivables Net Current | 121 | 185 | -34.6% |
| Inventory Finished Goods Net Of Reserves | 643 | 484 | +32.9% |
| Inventory Work In Process Net Of Reserves | 222 | 171 | +29.8% |
| Inventory Raw Materials And Supplies Net Of Reserves | 224 | 211 | +6.2% |
| Inventory | 1,089 | 866 | +25.8% |
| Other Assets Current | 754 | — | — |
| Total Current Assets | 3,583 | 3,053 | +17.4% |
| Non-Current Assets | |||
| Goodwill | 5,626 | 4,991 | +12.7% |
Show Business Segments breakouts |
|||
| Dental Solutions · Operating Segments | 470 | — | — |
| Health Information Systems · Operating Segments | 873 | — | — |
| MedSurg · Operating Segments | 4,176 | — | — |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 108 | — | — |
| Other Non-Current Assets | 848 | — | — |
| Total Assets | 14,097 | 14,527 | -3.0% |
| Operating Lease Right-of-Use Assets | 186 | — | — |
| Deferred Tax Assets | 303 | — | — |
| Other Assets | |||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 1,543 | — | — |
| Intangible Assets Net Excluding Goodwill | 2,497 | — | — |
| Current Liabilities | |||
| Debt Current | 505 | 100 | +405.0% |
| Accounts Payable | 699 | 604 | +15.7% |
| Accrued Liabilities | 337 | 356 | -5.3% |
| Deferred Revenue (Current) | 613 | 558 | +9.9% |
| Other Liabilities Current | 1,192 | — | — |
| Total Current Liabilities | 3,346 | 2,566 | +30.4% |
| Non-Current Liabilities | |||
| Long-Term Debt | 4,575 | 7,813 | -41.4% |
| Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent | 360 | 334 | +7.8% |
| Deferred Tax Liabilities | 161 | 226 | -28.8% |
| Finance Lease Liability Noncurrent | 207 | — | — |
| Other Non-Current Liabilities | 478 | 279 | +71.3% |
| Total Liabilities | 9,128 | 11,265 | -19.0% |
| Long-Term Debt (Q) | — | — | — |
Show Debt Instrument breakouts |
|||
| 5.40% Senior Notes Due 2029 · Senior Notes | 698 | 1,488 | -53.1% |
| 5.45% Senior Notes Due 2027 · Senior Notes | 349 | 995 | -64.9% |
| 5.45% Senior Notes Due 2031 · Senior Notes | 991 | 991 | 0.0% |
| 5.60% Senior Notes Due 2034 · Senior Notes | 1,634 | 1,636 | -0.1% |
| 5.90% Senior Notes Due 2054 · Senior Notes | 1,210 | 1,232 | -1.8% |
| 6.00% Senior Notes Due 2064 · Senior Notes | 42 | 492 | -91.5% |
| Credit Facilities · Three year senior term loan credit facility | 110 | 979 | -88.8% |
| Stockholders' Equity | |||
| Common Stock | 2 | 2 | 0.0% |
| Additional Paid-In Capital | 3,895 | 3,781 | +3.0% |
| Retained Earnings | 1,810 | 378 | +378.8% |
| Treasury Stock Common Value | -67 | — | — |
| Accumulated Other Comprehensive Income | -670 | -899 | +25.5% |
| Total Stockholders' Equity | 4,969 | 3,262 | +52.3% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | -477 | -512 | +6.8% |
| Accumulated Gain Loss Net Cash Flow Hedge Parent | -1 | 9 | -111.1% |
| Accumulated Other Comprehensive Income | -670 | -899 | +25.5% |
| Accumulated Translation Adjustment | -193 | -396 | +51.3% |
| Additional Paid In Capital | 3,895 | 3,781 | +3.0% |
| Common Stock | 2 | 2 | 0.0% |
| Retained Earnings | 1,810 | 378 | +378.8% |
| Treasury Stock Common | -67 | — | — |
| Total Liabilities & Equity | 14,097 | 14,527 | -3.0% |
| Common Stock Shares Issued | 174,454,292 | — | — |
Cash Flow Statement
| Metric | YTD Q1 2026 | YTD Q1 2025 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 135 | 129 | +4.7% |
| Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash | 14 | 15 | -6.7% |
| Stock-Based Compensation | 51 | 49 | +4.1% |
| Deferred Income Taxes | -41 | -144 | +71.5% |
| Change in Accounts Receivable | -34 | 6 | -666.7% |
| Increase Decrease In Due From Related Parties | 28 | 5 | +460.0% |
| Change in Inventory | -32 | -32 | 0.0% |
| Change in Accounts Payable | 23 | 9 | +155.6% |
| Increase Decrease In Due To Related Parties | -100 | -6 | -1566.7% |
| Increase Decrease In Accrued Salaries | -151 | -107 | -41.1% |
| Other Operating Activities Cash Flow Statement | -94 | -32 | -193.8% |
| Net Cash from Operations | -189 | 29 | -751.7% |
| Investing Activities | |||
| Capital Expenditures | -84 | -109 | +22.9% |
| Other Investing Activities | 7 | -5 | +240.0% |
| Net Cash from Investing | -77 | -114 | +32.5% |
| Financing Activities | |||
| Proceeds From Debt Net Of Issuance Costs | 46 | — | — |
| Payments For Proceeds From Parent | 2 | -31 | +106.5% |
| Share Repurchases | -67 | — | — |
| Proceeds From Payments For Other Financing Activities | -31 | -8 | -287.5% |
| Net Cash from Financing | -50 | -139 | +64.0% |
| Supplemental | |||
| Right Of Use Asset Obtained In Exchange For Finance Lease Liability | 207 | — | — |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -2 | 1 | -300.0% |
| Net Change in Cash | -318 | -223 | -42.6% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 561 | 534 | +5.1% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.